Updates on the Detroit Cardiogenic Shock Initiative: It’s Gone National
Dr. Bill O’Neill of Henry Ford Hospital and Dr. Ted Schreiber of Detroit Medical Center discuss updates on the Detroit Cardiogenic Shock Initiative (CSI). Partnering hospital systems participating in DCSI use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of patients show survival rates have improved from 50% to 76%. Learn how your institution can participate.
- The need to adopt protocols to improve outcomes
- What was the Detroit Cardiogenic Shock Initiative?
- Key elements of this approach
- Adopting Protocols Has Shown to Increase Survival
- Learn more
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information